Texas Pacific Land returned 37% per year, beating the impressive 18% annual return of the Nasdaq Composite. See why I'm bullish on TPL stock.

Innoviva's shift to specialty therapeutics is backed by strong financials and a robust pipeline. Read why INVA stock presents ...